HAL vs TVTX · P/E 9.3, $19.05B cap vs rev $233.2M
Halliburton Company (HAL) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported TVTX revenue for 2024-12-31 was $233.2M. Net income was -$321.5M. Revenue was up 417.5% from 2023-12-31 to 2024-12-31. TVTX currently screens at market cap $1.33B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the HAL and TVTX stock pages for the full models.
Not investment advice.